Last Price
0.005
Today's Change
-0.004 (44.44%)
Day's Change
0.005 - 0.008
Trading Volume
33,705,292
Market Cap
4 Million
Shares Outstanding
902 Million
Avg Volume
1,381,370
Avg Price (50 Days)
0.01
Avg Price (200 Days)
0.03
PE Ratio
-0.50
EPS
-0.01
Earnings Announcement
27-Feb-2025
Previous Close
0.01
Open
0.01
Day's Range
0.005 - 0.008
Year Range
0.005 - 0.11
Trading Volume
33,705,292
1 Day Change
5 Day Change
1 Month Change
3 Month Change
6 Month Change
Ytd Change
1 Year Change
3 Year Change
5 Year Change
10 Year Change
Max Change
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. Biotron Limited was incorporated in 1999 and is headquartered in Sydney, Australia.